Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Feature

Hypoglycemia Patient Questionaire, Treating Hypoglycemia, and Hypoglycemia Classification

A task force report by the ADA and Endocrine Society have updated hypoglycemia categories, providing a new way to classify hypoglycemia in the absence of blood glucose readings and to help customize diabetes treatments for hypoglycemia.


What the Professionals Have to Say about the New SGLT2 Inhibitors

An abundance of excitement has surrounded the FDA approval of the sodium glucose cotransporter 2 inhibitor (SGLT2 –I), Invokana. So why did we need to introduce a 14th class of medication for treating diabetes? That answer was...


How the Liver Affects Insulin and Vice Versa: Part 2, Obesity and Lipid Metabolism

Andre McMahon, PharmD Candidate, University of Florida College of Pharmacy Dave Joffe, Editor-in-chief, Diabetes In...



Diabetes Health Record

  Developed by the Diabetes Coalition of California, the...


Top Ten Things to Know: 2011 Effectiveness-Based Guidelines for the Prevention of CVD in Women

  In 2007, CVD caused about 1 death per minute among women in the US.


Your Patients' Guide to Better Office Visits

 


Diabetes Mellitus and Infectious Diseases: Controlling Chronic Hyperglycemia

Kristin Robinson, PharmD Candidate FAMU College of Pharmacy Introduction As the incidence of diabetes mellitus continues to rise, common focus areas for diabetes...


How the Liver Affects Insulin and Vice Versa: Part 1 Carbohydrate Metabolism

Dave Joffe, Editor-in-chief, Diabetes In Control Andre McMahon, Ben Mitrano, PharmD Candidates, University of Florida College of...


NDEP Fast Facts on Diabetes 2011

From the Centers for Disease Control and Prevention, this is the most recent National Diabetes Fact Sheet...


Contract for Starting a New Habit


Kidney Stones in Relation to Obesity and Diabetes

Amanda Zell, Doctor of Pharmacy Candidate, Mercer University A kidney stone is a solid mass developed from crystals that separate from the urine within the urinary tract.


Inpatient Diabetes Nurse Practitioner (2 positions available)

Two positions (1 full time, 1 part time) are available for an Advanced Practice nurse at Hinsdale Hospital. 


Importance of Physical Activity Studies (pdf)

  Show your patients this short list of some of the studies demonstrating...


SPECIAL FEATURE ARTICLE: The Effects of GLP-1 Agonists -- A Review of the Drug Class

Amanda Zell, PharmD Candidate, Mercer University College of Pharmacy Glucagon-like peptide-1 (GLP-1) is part of a family of peptide hormones known as incretins.


Top 10 Sodium Overkill Culprits (Patient Handout)

  Nine out of 10 Americans consume more sodium than they need, according to a new report...


Important Labs in Diabetes Control


GLP-1 Analogs, Appetite and Satiety

Cierra Harden PharmD Candidate 2013 LECOM School of Pharmacy, Bradenton Obesity is a major risk factor for the development of diabetes as well as predisposing individuals to hypertension...


The Use of GLP-1 Analogs and Lifestyle Changes

Alan Mathis PharmD Candidate 2013 University of Florida GLP-1 analogs not only improve plasma glucose levels and reduce HbA1c, but also improve metabolic effects such as reduction in...


GLP-1 Agonists and Lifestyle Changes: A Recipe for Success

Andre McMahon, PharmD Candidate UF College of Pharmacy Achieving glycemic control is a critical goal in the management of patients with type 2 diabetes mellitus (DM).


Understanding Metformin Handout (pdf)

    What every patient needs to know about metformin.


GLP-1 Agonist Effects on Glucagon Suppression

Alan Mathis, PharmD Candidate 2013, University of Florida College of Pharmacy The pathophysiology of type-2 diabetes is characterized by insulin resistance and beta-cell...


Chronicle Diabetes

 


Marketing Project Manager

We are the leading digital diabetes media company dedicated to equipping frontline medical practitioners to battle the diabetes epidemic. 


LEAP Program: Free Monofilaments

    This monofilament, produced by the Lower...


Care4Today Mobile Adherence App

 


The Effects of GLP-1 on Cardiovascular Health

Tina Burge, Doctor of Pharmacy Candidate, FAMU College of Pharmacy Reviewed by Dave Joffe, BSPharm, CDE It's well-known...


My Healthy Waist iPad App

 


STEP-Wise™ Approach


Endocrine Society Chemical Screening Recommendations

David Joffe, BSPharm, CDE, Editor-in-chief, Diabetes In Control The Endocrine Society has published a new set of recommendations on the definition of endocrine-disrupting chemicals (EDC) and screening programs for such...


Free Safe at School HCP Toolkit


Know Your Healthy Steps

  Learn how to get your patients to increase their physical...


GLP-1: Actions on Beta-cell Mass and Function

David Joffe, BSPharm, CDE Tina Burge, PharmD Candidate Florida A&M University


More Than 50 Ways to Prevent Diabetes

This tip sheet helps patients at risk for...


SGLT Inhibitors

by Erica Paul, PharmD, Graduate Intern University of Florida College of Pharmacy    


An Educator's Perspective: Janet Carson, R.N., C.D.E., Largo, FL

Often times there can be difficulty getting approval for the patient to use a GLP-1 analog and so the patient may miss a few days of the medication and possibly decide they don't want to continue. I have gotten in the habit of ordering the...


Male Testosterone Questionnaire

With the increase in obesity rates, there has also been a corresponding increase in the number of men diagnosed with low testosterone levels.


GLP-1 Agonists: Increasing Effective Insulin Release

By Wael Diab, RPh, PharmD Candidate University of Colorado College of Pharmacy The pathophysiology of type 2 diabetes mellitus is complex, consisting of far more physiologic defects than simple...


A Primary Care Physician's Perspective: Dr. Norris Brown, Austin, TX

When the GLP-1 analogs first came out I was slow to start using them. As a primary care physician in a busy multi-practitioner office I was used to working with oral medications for diabetes, and only as a last resort would I put patients on...


Endobarrier (R)

Report by Jacqueline Vogt, PharmD Candidate, UF College of Pharmacy More than one-third of adults and approximately 17% of children and adolescents...


The EmPower Diabetes Emergency Plan

ACE and Lilly Diabetes have launched the "EmPower Diabetes Emergency Plan" with comprehensive tips to help...



Navigate through our listing of Feature articles here.
Next Last

310 Total articles for Feature


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here

 
Diabetes In Control Advertisers
 
Cast Your Vote
Should a person newly diagnosed with prediabetes be treated with medication along with lifestyle changes?

Navigate Diabetes In Control
CME/CE of the Week
Derek LeRoith, MD

Category: General Diabetes
Credits: .5


Advertisement


Search Articles On Diabetes In Control